The Best 3 Nuclear Energy Stocks to Buy and Hold for Decades

The article is broadly constructive on nuclear energy stocks, highlighting Cameco’s 17% share of global uranium production in 2024, 11% revenue growth to $3.48 billion in 2025, and 26% adjusted EBITDA growth. Constellation Energy is targeting more than 20% EPS growth through 2029, while also planning nearly $4 billion of growth capex, a 10% dividend increase in 2026, and another $5 billion of buybacks this year. Oklo is the highest-risk name but got a credibility boost from its Nvidia and Los Alamos collaboration; the piece frames all three as long-term beneficiaries of AI-driven power demand.

Analysis

The cleanest takeaway is that this is not a uniform “nuclear trade” but a three-layer capital stack: upstream fuel leverage, regulated cash-flow compounding, and speculative project optionality. That matters because AI-driven power demand does not benefit all nuclear exposures equally; the market is likely to keep paying up for visible cash conversion while underpricing the bottlenecks that could slow reactor deployment. In that framework, CCJ is the most direct hedge on fuel scarcity, but its multiple already assumes a multi-year tight market, so incremental upside now depends more on contract repricing than on spot uranium alone.

CEG is the best second-order beneficiary because it monetizes scarcity without bearing commodity risk to the same degree. If hyperscale demand continues to force long-dated clean baseload procurement, the key variable becomes not just power prices but the duration of contracted spreads; that supports both buybacks and dividend growth while making the equity less sensitive to near-term macro noise. The market’s mistake is likely underestimating how much optionality regulated nuclear fleet owners have when data-center load growth turns into a capacity auction rather than an electricity consumption story.

OKLO is the highest-beta way to express the theme, but the real catalyst is not partnership headlines — it is de-risking of licensing and first-of-a-kind execution. The stock can rerate violently on any regulatory milestone, but the downside is equally path-dependent if commercialization slips by even 12-18 months. The broader contrarian point: the consensus is focused on demand growth, but supply-chain scarcity, permitting, and grid interconnection delays are the true constraints, which could keep leaders expensive longer than bears expect while crushing the timeline for pre-revenue names.

Key Decisions for Investors

• Long CEG vs short a basket of utilities with lower nuclear exposure over 3-6 months; thesis is that AI-driven load growth rewards scarce baseload assets with balance-sheet capacity to return capital, while the basket lags on less visible earnings growth.
• Buy CCJ on pullbacks only, using a 6-12 month horizon; treat it as a structural uranium tightness trade, but avoid chasing strength because the current multiple leaves little room for contract or spot disappointment.
• Speculative long OKLO via call spreads into regulatory/catalyst windows over 3-9 months; define risk tightly because any licensing delay can halve the stock, but a credible approval or deployment milestone can produce multi-bagger convexity.
• Pair trade: long CEG / short CCJ for a relative-value expression of the theme; CEG has stronger near-term cash flow visibility and capital return support, while CCJ is more exposed to already-discounted commodity optimism.
• If seeking lower-volatility exposure, prefer CEG over OKLO/CCJ until the market confirms the next leg of AI power procurement; the risk/reward is better because upside is driven by earnings compounding rather than a binary execution path.